EyeGate Pharmaceuticals, Inc. Employee Directory

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

Traded on Nasdaq Capital Market, stock symbol EYEG, EyeGate is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye.

Our most advanced platform is based on a crosslinked thiolated carboxymethyl hyaluronic acid (“CMHA-S”), a modified form of the natural polymer hyaluronic acid (“HA”), which is a gel that possesses unique physical and chemical properties such as hydrating and healing when applied to the ocular surface.

Our first CMHA-S-based product candidate, the EyeGate Ocular Bandage Gel (“OBG”), is a topically applied eye drop formulation that has completed its first-in-man clinical trial for the healing and lubricating of large epithelial defects following treatment after photorefractive keratectomy (“PRK”) surgery.

Our initial product candidate from our second platform is EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, that is delivered into the ocular tissues through our proprietary innovative iontophoresis drug delivery system, the EyeGate® II Delivery System. 

More than 2,400 treatments have been administered to date using our EyeGate® II Delivery System in clinical trials. EGP-437 is currently in clinical development for the treatment of various inflammatory conditions of the eye, including ocular inflammation and pain in post-surgical cataract patients and the treatment of uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea. 

EyeGate has entered into two exclusive, worldwide licensing agreements with subsidiaries of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (“Valeant”) through which we have granted Valeant an exclusive, worldwide commercial and manufacturing rights to the EGP-437 combination product for the treatment of uveitis and post-operative ocular inflammation and pain in ocular surgery patients.

Find EyeGate Pharmaceuticals, Inc. employees' phone numbers or email addresses

EyeGate Pharmaceuticals, Inc. Global Highlights

Location
Employees

North America
6

Minus sign iconPlus sign icon
  • United States Of America
    6

Asia
1

Minus sign iconPlus sign icon
  • Philippines
    1

EyeGate Pharmaceuticals, Inc.'s Leadership

  • Stylized image of a person
    P. A.
    President, Chief Executive Officer And A Director
    Phone icon
  • Stylized image of a person
    K. S.
    Senior Quality Assurance Manager
    Phone icon
  • Stylized image of a person
    C. G.
    Principal
    Phone icon
  • Stylized image of a person
    M. A.
    Metrologist
    Phone icon

Contact profiles from EyeGate Pharmaceuticals, Inc.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    P. A.
    President, Chief Executive Officer And A Director
    Phone icon
    Oct 23, 2024
  • Stylized image of a person
    K. S.
    Senior Quality Assurance Manager
    Phone icon
    UNITED STATES
    Oct 21, 2024
  • Stylized image of a person
    C. G.
    Principal
    Phone icon
    Oct 17, 2024
  • Stylized image of a person
    M. A.
    Metrologist
    Phone icon
    Oct 21, 2024

Frequently Asked Questions

What is EyeGate Pharmaceuticals, Inc. known for?

Minus sign iconPlus sign icon
EyeGate Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry; you can contact the main corporate office by phone at . Explore EyeGate Pharmaceuticals, Inc.'s company overview page for more information.

What is EyeGate Pharmaceuticals, Inc.'s most common email format?

Minus sign iconPlus sign icon
EyeGate Pharmaceuticals, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more EyeGate Pharmaceuticals, Inc. email formats with LeadIQ.

How many employees does EyeGate Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
EyeGate Pharmaceuticals, Inc. has approximately 17 employees as of December 2025. These team members are located across 2 continents, including North AmericaAsia.

Who are EyeGate Pharmaceuticals, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, EyeGate Pharmaceuticals, Inc.'s key employees include:

  • President, Chief Executive Officer And A Director: P. A.
  • Senior Quality Assurance Manager: K. S.
  • Principal: C. G.
  • Metrologist: M. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.